When did McKesson report Q3 2026 earnings?

McKesson (MCK) reported Q3 2026 earnings on February 4, 2026 after market close.

What were McKesson's Q3 2026 revenue and EPS?

McKesson reported revenue of $106.16B and diluted EPS of $9.34 for Q3 2026.

Did McKesson beat estimates in Q3 2026?

Revenue beat the consensus estimate of $105.80B by $362.8M. EPS beat the consensus estimate of $9.17 by $0.17.

How did McKesson's Q3 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 11.4% from $95.3B a year earlier and diluted EPS grew 16.3% from $8.03.

Where can I find McKesson's Q3 2026 SEC filings?

You can read the 8-K earnings release (0000927653-26-000015) and the 10-Q periodic report (0000927653-26-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.

McKesson MCK Q3 2026 earnings

Reported February 4, 2026 · After market close

Revenue$106.16BBeat by $362.8M Diluted EPS$9.34Beat by $0.17

Revenue estimate$105.80B

EPS estimate$9.17

Next report

Aug 5, 2026 (in a month)

Revenue estimate$104.00B

EPS estimate$9.63

Financials

Q3 2026

Income statement

See full

Revenue$106.16B+11.4%

Gross profit$3.7B+12.2%

Operating income$1.6B+32.3%

Net income$1.2B+34.9%

EPS (diluted)$9.59+38.0%

Balance sheet

See full

Cash & equivalents$3.1B+138%

Total debt$9.8B+0.3%

Total equity-$1.3B+57.9%

Total assets$84.2B+18.4%

Cash flow

See full

Operating cash flow$1.2B+152%

CapEx$108.0M-14.3%

Free cash flow$1.1B+145%

Valuation & ratios

Q3 2026

Valuation

See full

Market cap$101.25B+39.9%

Enterprise value$107.99B+33.6%

P/E23.3×-2.3×

P/S0.3×0.0×

Profitability

See full

Gross margin3.6%-0.3pp

Operating margin1.4%+0.2pp

Net margin1.1%+0.3pp

FCF margin2.5%+2.0pp

Returns & leverage

See full

Current ratio0.9×0.0×

Segments

By segment

See full

North American Pharmaceutical$88.3B—

Oncology & Multispecialty$13.0B—

Medical-Surgical Solutions$3.0B+1.4%

Prescription Technology Solutions$1.5B+9.4%

Versus estimates

Revenue

Q4 2026$96.3BMiss by $5.1B

Q3 2026$106.16BBeat by $362.8M

Q2 2026$103.15BMiss by $986.3M Q1 2026$97.8BBeat by $1.6B Q4 2025$90.8BMiss by $3.5B Q3 2025$95.3BMiss by $760.8M

Diluted EPS

Q4 2026$11.69Beat by $0.13

Q3 2026$9.34Beat by $0.17

Q2 2026$9.86Beat by $0.83 Q1 2026$8.26Beat by $0.12 Q4 2025$10.12Beat by $0.29 Q3 2025$8.03Miss by $0.57

Ask the moment McKesson reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did McKesson report Q3 2026 earnings?: McKesson (MCK) reported Q3 2026 earnings on February 4, 2026 after market close.
What were McKesson's Q3 2026 revenue and EPS?: McKesson reported revenue of $106.16B and diluted EPS of $9.34 for Q3 2026.
Did McKesson beat estimates in Q3 2026?: Revenue beat the consensus estimate of $105.80B by $362.8M. EPS beat the consensus estimate of $9.17 by $0.17.
How did McKesson's Q3 2026 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 11.4% from $95.3B a year earlier and diluted EPS grew 16.3% from $8.03.
Where can I find McKesson's Q3 2026 SEC filings?: You can read the 8-K earnings release (0000927653-26-000015) and the 10-Q periodic report (0000927653-26-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.